Surfactant treatment at birth in a contemporary cohort of preterm infants with bronchopulmonary dysplasia

Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl J Med 1967;276:357–68.

Article  PubMed  Google Scholar 

Tracy MK, Berkelhamer SK. Bronchopulmonary dysplasia and pulmonary outcomes of prematurity. Pediatr Ann. 2019;48:e148–e153.

Article  PubMed  Google Scholar 

Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100:145–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, et al. Bronchopulmonary dysplasia. Nat Rev Dis Prim. 2019;5:78.

Article  PubMed  Google Scholar 

Dumpa V, Bhandari V. Surfactant, steroids and non-invasive ventilation in the prevention of BPD. Semin Perinatol. 2018;42:444–52.

Article  PubMed  Google Scholar 

Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641–3.

Article  CAS  PubMed  Google Scholar 

Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, et al. Revisiting the definition of bronchopulmonary dysplasia: effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr. 2017;171:271–9.

Article  PubMed  Google Scholar 

Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Ann Am Thorac Soc. 2015;12:1822–30.

Article  PubMed  PubMed Central  Google Scholar 

Hines D, Modi N, Lee SK, Isayama T, Sjörs G, Gagliardi L, et al. Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus. Acta Paediatr. 2017;106:366–74.

Article  PubMed  Google Scholar 

Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.

Article  CAS  PubMed  Google Scholar 

Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12–28.e1.

Article  PubMed  Google Scholar 

Guaman MC, Pishevar N, Abman SH, Keszler M, Truog WE, Panitch H, et al. Invasive mechanical ventilation at 36 weeks post-menstrual age, adverse outcomes with a comparison of recent definitions of bronchopulmonary dysplasia. J Perinatol. 2021;41:1936–42.

Article  PubMed  PubMed Central  Google Scholar 

Jensen EA, Edwards EM, Greenberg LT, Soll RF, Ehret DEY, Horbar JD. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics. 2021;148:e2020030007.

Article  PubMed  Google Scholar 

Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res. 2017;81:240–8.

Article  PubMed  Google Scholar 

Gallacher DJ, Hart K, Kotecha S. Common respiratory conditions of the newborn. Breathe. 2016;12:30–42.

Article  PubMed  PubMed Central  Google Scholar 

Lane MD, Kishnani S, Udemadu O, Danquah SE, Treadway RM, Langman A, et al. Comparative efficacy and safety of late surfactant preparations: a retrospective study. J Perinatol. 2021;41:2639–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. North American Study Group. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21:109–19.

Article  PubMed  Google Scholar 

Lee SK, Beltempo M, McMillan DD, Seshia M, Singhal N, Dow K, et al. Evidence-based practice for improving quality investigators. Outcomes and care practices for preterm infants born at less than 33 weeks’ gestation: a quality-improvement study. CMAJ. 2020;192:E81–E91.

Article  PubMed  PubMed Central  Google Scholar 

Govindaswami B, Nudelman M, Narasimhan SR, Huang A, Misra S, Urquidez G, et al. Eliminating risk of intubation in very preterm infants with noninvasive cardiorespiratory support in the delivery room and neonatal intensive care unit. Biomed Res Int. 2019;2019:5984305.

Article  PubMed  PubMed Central  Google Scholar 

Weisz DE, Yoon E, Dunn M, Emberley J, Mukerji A, Read B, et al. Canadian neonatal network investigators. Duration of and trends in respiratory support among extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2021;106:286–91.

Article  PubMed  Google Scholar 

Bellos I, Fitrou G, Panza R, Pandita A. Comparative efficacy of methods for surfactant administration: a network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2021;106:474–87.

Article  PubMed  Google Scholar 

Härtel C, Glaser K, Speer CP. The Miracles of Surfactant: Less Invasive Surfactant Administration, Nebulization, and Carrier of Topical Drugs. Neonatology. 2021;118:225–34.

Article  PubMed  Google Scholar 

Kothe TB, Sadiq FH, Burleyson N, Williams HL, Anderson C, Hillman NH. Surfactant and budesonide for respiratory distress syndrome: an observational study. Pediatr Res. 2020;87:940–5.

Article  CAS  PubMed  Google Scholar 

Lal CV, Ambalavanan N. Biomarkers, early diagnosis, and clinical predictors of bronchopulmonary dysplasia. Clin Perinatol. 2015;42:739–54.

Article  PubMed  PubMed Central  Google Scholar 

Wang SH, Tsao PN. Phenotypes of bronchopulmonary dysplasia. Int J Mol Sci. 2020;21:6112.

Article  PubMed  PubMed Central  Google Scholar 

Bamat NA, Zhang H, McKenna KJ, Morris H, Stoller JZ, Gibbs K. The clinical evaluation of severe bronchopulmonary dysplasia. Neoreviews. 2020;21:e442–e453.

Article  PubMed  Google Scholar 

Logan JW, Lynch SK, Curtiss J, Shepherd EG. Clinical phenotypes and management concepts for severe, established bronchopulmonary dysplasia. Paediatr Respir Rev. 2019;31:58–63.

PubMed  Google Scholar 

Wu KY, Jensen EA, White AM, Wang Y, Biko DM, Nilan K, et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201:1398–406.

Article  PubMed  PubMed Central  Google Scholar 

Higano NS, Spielberg DR, Fleck RJ, Shapiro AH, Walkup LL, Hahn AD, et al. Neonatal pulmonary magnetic resonance imaging of bronchopulmonary dysplasia predicts short-term clinical outcomes. Am J Respir Crit Care Med. 2018;198:1302–11.

Article  PubMed  PubMed Central  Google Scholar 

Shepherd EG, Clouse BJ, Hasenstab KA, Sitaram S, Malleske DT, Nelin LD, et al. Infant pulmonary function testing and phenotypes in severe bronchopulmonary dysplasia. Pediatrics. 2018;141:e20173350.

Article  PubMed  Google Scholar 

Morrow LA, Wagner BD, Ingram DA, Poindexter BB, Schibler K, Cotten CM, et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med. 2017;196:364–74.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif